DESLANOSIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for deslanoside and what is the scope of freedom to operate?
Deslanoside
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for DESLANOSIDE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Clinical Trials: | 1 |
Patent Applications: | 1,600 |
DailyMed Link: | DESLANOSIDE at DailyMed |
Recent Clinical Trials for DESLANOSIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Alphacait, LLC | Phase 2 |
Medical Subject Heading (MeSH) Categories for DESLANOSIDE
Anatomical Therapeutic Chemical (ATC) Classes for DESLANOSIDE
US Patents and Regulatory Information for DESLANOSIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | CEDILANID-D | deslanoside | INJECTABLE;INJECTION | 009282-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |